Medscape "We note that we may have an increased risk of stent thrombosis within the very first hours [of STEMI], as the EuroMAX and HORIZONS trials have shown. If we perform a different strategy in the cath lab using unfractionated heparin and IV GP IIb/IIIa ... and more »
Medscape As previously reported by heartwire , the multicenter EUROMAX trial demonstrated that STEMI patients treated with bivalirudin had lower 30-day rates of death or...
TCTMD PARIS, France—In patients with ST-segment myocardial infarction (STEMI) being transported for primary percutaneous coronary intervention (PCI), upstream bivalirudin lowers mortality or major bleeding compared with heparin , an advantage that is ...
